Sora Cirrus
Resting-state fMRI software for brain imaging and surgical planning
Company profile
Company profile
Sora Neuroscience is a medical imaging company that develops advanced resting-state fMRI technology for brain patient care. The company's flagship product, CIRRUS, is FDA-cleared software that maps critical brain networks including the Sensorimotor Network, Language Network, and Vision Network. Built on decades of neuroscience research developed at Washington University in St. Louis, Sora's technology reveals powerful insights into brain health to support neurosurgical planning and treatment decisions. The company was founded by a team of neuroradiologists, neurosurgeons, data scientists, and commercial software developers with deep expertise in resting-state brain activity and AI machine learning. Sora partners with Washington University in St. Louis as the licensor of their core technology and intellectual property, and collaborates with Prism Clinical Imaging for validation testing and commercialization. Their software is designed to integrate with existing physician tools through open standards, supporting diagnosis and treatment planning for brain tumors, epilepsy, and other neurological disorders. The company's mission centers on giving patients and families more quality time together through better-informed clinical decisions.
Company description Sora Neuroscience official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Other deployment with recorded integration context.
Company milestones
FDA clearance for CIRRUS platform covering three resting state networks (Sensorimotor, Language, Vision)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Resting-state fMRI software for brain imaging and surgical planning
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
K251009 · 510k · Jun 6, 2025
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
Stephen Schaefer
CEO
Eric Leuthardt
Co-Founder
Daniel Marcus
Co-Founder
Timothy Schaewe
Director of Technology & R&D
Tara Butler
Business Development Director
Rebecca Welty
Director of Quality
Patrick Campbell
Head of Product & Engineering
Pratik Patel
Head of Commercial
06 · Company updates
Recent articles published on Sora Neuroscience's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.